In addition to primary educational activities SAIMAH creates value for its members by undertaking various advocacy and awareness building campaigns. SAIMAH considers such activities as critical to its mission. The advocacy includes educating various agencies such as FDA and CMS, and legislative branches of government about the emerging technologies, patient safety issues, regulatory issues, and efficacy. SAIMAH also helps agencies and members in designing clinical trials as well as helping create other approval options.